Therapeutic compounds comprised of anti-Fc receptor antibodies

Details for Australian Patent Application No. 2003200884 (hide)

Owner Medarex, Inc.

Inventors Goldstein, Joel; Graziano, Robert; Deo, Yashwant M.; Somasundaram, Chezian

Agent Shelston IP

Pub. Number AU-B-2003200884

Parent 53373

Filing date 28 February 2003

Wipo publication date 12 June 2003

Acceptance publication date 30 November 2006

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

20 March 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2003200884

30 November 2006 Application Accepted

  Published as AU-B-2003200884

29 March 2007 Standard Patent Sealed

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200885-Insulating sheet material

2003200883-Multiple-tumor aberrant growth genes